Taiwan FDA registration 8d91d62ce55faa31a9db4b8e9636c64d

BioMérieux latex agglutination anti-methicillin Staphylococcus aureus assay set

TW: 生物梅里埃乳膠凝集抗甲氧苯青黴素金黃色葡萄球菌測定試劑組
Taiwan flagTaiwan·BIOMERIEUX S.A.(IN MARCY)·Registered Dec 10, 2005 – Dec 10, 2010Cancelled
Registration details
Analysis ID
8d91d62ce55faa31a9db4b8e9636c64d
Customs Code
DHA00601542602
Company information
Manufacturer Country
France
Product details
Intended Use
By detecting PBP2, latex agglutination was used to rapidly detect methoxybenzenylpenicillin-resistant Staphylococcus aureus.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.1640 抗菌感受性試驗粉末
Import Information
import
Dates and status
Registration Date
Dec 10, 2005
Expiry Date
Dec 10, 2010
Cancellation Date
Nov 27, 2012
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for BioMérieux latex agglutination anti-methicillin Staphylococcus aureus assay set in Taiwan's medical device market through Pure Global AI's free database. is registered under number 8d91d62ce55faa31a9db4b8e9636c64d and manufactured by BIOMERIEUX S.A.(IN MARCY). The authorized representative in Taiwan is BIOMERIEUX CHINA LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices